ARL6IP5 and esophageal cancer: Silencing JWA expression can reduce the expression level of light chain 3 (LC3-I/II) in TE1 cells after cisplatin treatment, and JWA may affect the sensitivity of esophageal cancer cells to cisplatin by regulating autophagy [115].